Khalid Alhazzani

13PUBLICATIONS
26CO-AUTHORS
Molecular targetsHaematological tumoursPharmaceutical delivery technologiesElectrochemical energy storage and conversionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 25, 2026
Exploiting the intrinsic Michael-acceptor reactivity of osimertinib via thiol-functionalized carbon dots: a mechanistic fluorometric approach.

|Jan 09, 2026
Inhibition of store-operated calcium entry mitigates lipopolysaccharide-induced hepatotoxicity via modulating inflammatory and oxidative stress responses.

Mohammed Alqinyah, Abdullah S Alhamed, Yasseen A Alassmrry

|Dec 10, 2024
Integrating Metabolomics, Histopathology, and Cardiac Marker Analysis to Assess Valsartan's Efficacy in Mitigating Dasatinib-Induced Cardiac Toxicity in Sprague-Dawley Rats.

Khalid Alhazzani, Hanan Mohammed, Mohammad M Algahtani

|Nov 26, 2024
Therapeutic Effects of Liposomal Resveratrol in the Mitigation of Diabetic Nephropathy via Modulating Inflammatory Response, Oxidative Stress, and Apoptosis.

Khalid Alhazzani, Salah Q Alrewily, Abdullah R Alanzi

|Oct 30, 2024
Sol-gel derived ceramic nanocomposite CNFs anchored with a nanostructured CeO2 modified graphite electrode for monitoring the interaction of a selective tyrosine kinase inhibitor capmatinib with dsDNA.

Ahmed Z Alanazi, Khalid Alhazzani, Mohamed M El-Wekil

|Nov 25, 2023
The Combination of Radiation with PARP Inhibition Enhances Senescence and Sensitivity to the Senolytic, Navitoclax, in Triple Negative Breast Tumor Cells.

Abrar Softah, Moureq R Alotaibi, Ali R Alhoshani

Pageof 3

Frequent Collaborators

8 joint publications

Ahmed Z Alanazi

4 joint publications

Abdullah S Alhamed

3 joint publications

Ali R Alhoshani

2 joint publications

Tareq Saleh